Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

BNTCBNTC
12 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in BENITEC BIOPHARMA INC

GEODE CAPITAL MANAGEMENT, LLC holds 611,736 shares of BNTC (BENITEC BIOPHARMA INC), worth $8.2M as of 2026-Q2. The position was increased (+16.7% shares). BNTC represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$8.2M

Current Shares

611,736

Total Value Change

+$8.2M

Total Shares Change

+601,712

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
611,736
+16.7%
$8.2M0.0%$13.38
32
2026-Q1
Increased
524,104
+15.6%
$5.6M0.0%$10.46
31
2025-Q4
Increased
453,375
+3.4%
$6.1M0.0%$13.93
28
2025-Q3
Increased
438,505
+5.6%
$6.2M0.0%$13.99
29
2025-Q2
Increased
415,211
+77.6%
$4.9M0.0%$11.35
41
2025-Q1
Increased
233,820
+18.6%
$3M0.0%$13.43
31
2024-Q4
Increased
197,096
+134.7%
$2.5M0.0%$12.51
42
2024-Q3
Increased
83,987
+31.3%
$772,1250.0%$9.23
31
2024-Q2
Increased
63,975
+538.2%
$447,1840.0%$6.99
26
2024-Q1
Unchanged
10,024
0.0%
$51,3220.0%$5.25
0
2023-Q4
Unchanged
10,024
0.0%
$32,4770.0%$3.23
0
2023-Q3
New
10,024
-
$30,2720.0%$3.02
30

Other major holders of BNTC: Janus Henderson Group Ltd., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used